Corporate Social Responsibility and Managing Drugs in Sport

References

• Aguinis, H., & Glavas, A. (2012). What we know and don't know about corporate social responsibility: A review and research agenda. Journal of Management, 38(4), 932–968.
   Web of Science ®Google Scholar
• Anderson, L., & Jackson, S. (2013). Competing loyalties in sports medicine: Threats to medical professionalism in elite, commercial sport. International Review for the Sociology of Sport, 48(2), 238–256.
   Web of Science ®Google Scholar
• Aubel, O., & Ohl, F. (2014). An alternative approach to the prevention of doping in cycling. International Journal of Drug Policy, 25(6), 1094–1102.
   PubMed Web of Science ®Google Scholar
• AUS. (2009). 2009 Annual report. Brisbane: Australian University Sport.
   Google Scholar
• Babiak, K. (2010). The role and relevance of corporate social responsibility in sport: A view from the top. Journal of Management & Organization, 16(04), 528–549.
   Google Scholar
• Bennett, G., Ferreira, M., Lee, J., & Polite, F. (2009). The role of involvement in sports and sport spectatorship in sponsor's brand use: The case of Mountain Dew and action sports sponsorship. Sport Marketing Quarterly, 18(1), 14–24.
   Google Scholar
• Birchard, K. (2000). Past, present, and future of drug abuse at the Olympics. The Lancet, 356, 1008.
   PubMed Web of Science ®Google Scholar
• Borland, J., & Macdonald, R. (2003). Demand for sport. Oxford Review of Economic Policy, 19(4), 478–502.
   Web of Science ®Google Scholar
• Breitbarth, T., Walzel, S., Anagnostopoulos, C., & van Eekeren, F. (2015). Corporate social responsibility and governance in sport: “Oh, the things you can find, if you don't stay behind!”. Corporate Governance, 15(2), 254–273.
   Web of Science ®Google Scholar
• Buechel, B., Emrich, E., & Pohlkamp, S. (2016). Nobody's innocent: The role of customers in the doping dilemma. Journal of Sports Economics, 17(8), 767–789.
   Web of Science ®Google Scholar
• Caroll, A. (1979). A three-dimensional model of corporate performance. Academy of Management Review, 4(4), 497–505.
   Google Scholar
• Carstairs, C. (2003). The wide world of doping: Drug scandals, natural bodies, and the business of sports entertainment. Addiction Research & Theory, 11(4), 263–281.
   Web of Science ®Google Scholar
• Cisyk, J., & Courty, P. (2015). Do fans care about compliance to doping regulations in sports? The impact of PED suspension in baseball. Journal of Sports Economics. doi:10.1177/1527002515587441
   Web of Science ®Google Scholar
• Coakley, J. (2015). Assessing the sociology of sport: On cultural sensibilities and the great sport myth. International Review for the Sociology of Sport, 50(4–5), 402–406.
   Web of Science ®Google Scholar
• Connor, J. M., & Mazanov, J. (2010). The inevitability of scandal: Lessons for sponsors and administrators. International Journal of Sports Marketing and Sponsorship, 11(3), 29–37.
   Web of Science ®Google Scholar
• Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Coomber, R. (2014). How social fear of drugs in the non-sporting world creates a framework for doping policy in the sporting world. International Journal of Sport Policy and Politics, 6(2), 171–193.
   Google Scholar
• Critcher, C. (2014). New perspectives on anti-doping policy: From moral panic to moral regulation. International Journal of Sport Policy and Politics, 6(2), 153–169.
   Google Scholar
• Crompton, J. (2014). Potential negative outcomes from sponsorship for a sport property. Managing Leisure, 19(6), 420–441.
   Google Scholar
• Dahlsrud, A. (2008). How corporate social responsibility is defined: An analysis of 37 definitions. Corporate Social Responsibility and Environmental Management, 15(1), 1–13.
   Web of Science ®Google Scholar
• Day, C. A., Topp, L., Iversen, J., & Maher, L. (2008). Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian needle and syringe program survey. Drug and Alcohol Review, 27(5), 559–561.
   PubMed Web of Science ®Google Scholar
• Donnelly, P. (2015). What if the players controlled the game? Dealing with the consequences of the crisis of governance in sports. European Journal for Sport and Society, 12(1), 11–30.
   Web of Science ®Google Scholar
• Eichner, A., & Tygart, T. (2015). Adulterated dietary supplements threaten the health and sporting career of up‐and‐coming young athletes. Drug Testing and Analysis, 8(3–4), 304–306. doi:10.1002/dta.1899
   Web of Science ®Google Scholar
• Foster, G., O'Reilly, N., & Davila, A. (2016). Sports business management: Decision making around the globe. Abingdon: Routledge.
   Google Scholar
• Frenger, M., Emrich, E., & Pitsch, W. (2013). How to produce the belief in clean sports which sells. Performance Enhancement & Health, 2(4), 210–215.
   Google Scholar
• Garibaldi, D. (2006). The challenge and the tragedy. New England Law Review, 40, 717–729.
   Google Scholar
• Godfrey, P. (2009). Corporate social responsibility in sport: An overview and key issues. Journal of Sport Management, 23(6), 698–716.
   Web of Science ®Google Scholar
• Hanstad, D. V., Smith, A., & Waddington, I. (2008). The establishment of the World Anti-Doping Agency. International Review for the Sociology of Sport, 43(3), 227–249.
   Web of Science ®Google Scholar
• Henne, K., Koh, B., & McDermott, V. (2013). Coherence of drug policy in sports: Illicit inclusions and illegal inconsistencies. Performance Enhancement & Health, 2(2), 48–55.
   Google Scholar
• Jones, S. C. (2010). When does alcohol sponsorship of sport become sports sponsorship of alcohol? A case study of developments in sport in Australia. International Journal of Sports Marketing and Sponsorship, 11(3), 67–78.
   Web of Science ®Google Scholar
• Kimergård, A., & McVeigh, J. (2014). Variability and dilemmas in harm reduction for anabolic steroid users in the UK: A multi-area interview study. Harm Reduction Journal, 11(1), 19.
   PubMed Web of Science ®Google Scholar
• Kingsland, M., Wiggers, J., & Wolfenden, L. (2012). Interventions in sports settings to reduce alcohol consumption and alcohol-related harm: A systematic review protocol. BMJ Open, 2(2), e000645.
   Web of Science ®Google Scholar
• Levermore, R., & Moore, N. (2015). The need to apply new theories to “Sport CSR”. Corporate Governance, 15(2), 249–253.
   Web of Science ®Google Scholar
• Maennig, W. (2014). Inefficiency of the anti-doping system: Cost reduction proposals. Substance Use and Misuse, 49(9), 1201–1205.
   PubMed Web of Science ®Google Scholar
• Marcora, S. (2016). Can doping be a good thing? Using psychoactive drugs to facilitate physical activity behaviour. Sports Medicine, 46, 1–5.
   Web of Science ®Google Scholar
• Maughan, R. J. (2013). Quality assurance issues in the use of dietary supplements, with special reference to protein supplements. The Journal of Nutrition, 143(11), 1843S–1847S.
   PubMed Web of Science ®Google Scholar
• Mazanov, J. (2014). Drug control in sport: Who and how. In B. Stewart & M. Burke ( Eds.), Drugs and sport: Writings from the edge (pp. 33–71). Melbourne: Dry Ink Press.
   Google Scholar
• Mazanov, J. (2016). Beyond anti-doping and harm minimisation: A stakeholder-corporate social responsibility approach to drug control for sport. Journal of Medical Ethics, 42(4), 220–223.
   PubMed Web of Science ®Google Scholar
• Mazanov, J. (2017). Managing drugs in sport. Abingdon: Routledge.
   Google Scholar
• Mazanov, J., Huybers, T., & Connor, J. (2011). Qualitative evidence of a primary intervention point for elite athlete doping. Journal of Science and Medicine in Sport, 14(2), 106–110.
   PubMed Web of Science ®Google Scholar
• McDermott, V. (2016). The war on drugs in sport. Abingdon: Routledge.
   Google Scholar
• Miles, S. (2012). Stakeholder: Essentially contested or just confused? Journal of Business Ethics, 108(3), 285–298.
   Web of Science ®Google Scholar
• Morgeson, F. P., Aguinis, H., Waldman, D. A., & Siegel, D. S. (2013). Extending corporate social responsibility research to the human resource management and organizational behavior domains: A look to the future. Personnel Psychology, 66(4), 805–824.
   Web of Science ®Google Scholar
• Møldrup, C., & Rie Hansen, R. (2006). Public acceptance of drug use for non-disease conditions. Current Medical Research and Opinion, 22(4), 775–180.
   PubMed Web of Science ®Google Scholar
• Møldrup, C., Traulsen, J. M., & Almarsdóttir, A. B. (2003). Medically‐enhanced normality: An alternative perspective on the use of medicines for non‐medical purposes. International Journal of Pharmacy Practice, 11(4), 243–249.
   Google Scholar
• Møller, V., & Dimeo, P. (2014). Anti-doping – the end of sport. International Journal of Sport Policy and Politics, 6(2), 259–272.
   Google Scholar
• Møller, V., Waddington, I., & Hoberman, J. (2015). Routledge handbook of drugs and sport (6th ed.). Oxon: Routledge.
   Google Scholar
• Mottram, D. (2015a). The evolution of doping and anti-doping in sport. In D. Mottram & N. Chester ( Eds.), Drugs in sport (6th ed., pp. 21–36). Oxon: Routledge.
   Google Scholar
• Mottram, D. (2015b). Drugs and their use in sport. In D. Mottram & N. Chester ( Eds.), Drugs in sport (pp. 3–20). Oxon: Routledge.
   Google Scholar
• Nicholson, M., & Hoye, R. (2008). Sport and social capital: An introduction. In M. Nicholson & R. Hoye ( Eds.), Sport and social capital (pp. 1–18). Oxon: Routledge.
   Google Scholar
• Nieper, A. (2005). Nutritional supplement practices in UK junior national track and field athletes. British Journal of Sports Medicine, 39(9), 645–649.
   PubMed Web of Science ®Google Scholar
• O'Brien, K. S., Kolt, G. S., Martens, M. P., Ruffman, T., Miller, P. G., & Lynott, D. (2012). Alcohol-related aggression and antisocial behaviour in sportspeople/athletes. Journal of Science and Medicine in Sport, 15(4), 292–297.
   Web of Science ®Google Scholar
• O'Brien, K. S., & Kypri, K. (2008). Alcohol industry sponsorship and hazardous drinking among sportspeople. Addiction, 103(12), 1961–1966.
   PubMed Web of Science ®Google Scholar
• Okoye, A. (2009). Theorising corporate social responsibility as an essentially contested concept: Is a definition necessary? Journal of Business Ethics, 89(4), 613–627.
   Web of Science ®Google Scholar
• Orchard, J. W., Steet, E., Massey, A., Dan, S., Gardiner, B., & Ibrahim, A. (2010). Long-term safety of using local anesthetic injections in professional rugby league. The American Journal of Sports Medicine, 38(11), 2259–2266.
   PubMed Web of Science ®Google Scholar
• Paramio-Salcines, J., Babiak, K., & Walters, G. (2013). Routledge handbook of sport and corporate social responsibility. Oxon: Routledge.
   Google Scholar
• Partridge, B., Lucke, J., & Hall, W. (2014). “If you're healthy you don't need drugs”: Public attitudes towards “brain doping” in the classroom and “legalised doping” in sport. Performance Enhancement & Health, 3(1), 20–25.
   Google Scholar
• Pipe, A., & Ayotte, C. (2002). Nutritional supplements and doping. Clinical Journal of Sport Medicine, 12(4), 245–249.
   PubMed Web of Science ®Google Scholar
• Rowe, N. F. (2015). Sporting capital: A theoretical and empirical analysis of sport participation determinants and its application to sports development policy and practice. International Journal of Sport Policy and Politics, 7(1), 43–61.
   Web of Science ®Google Scholar
• Savulescu, J., ter Meulen, R., & Kahane, G. (2011). Enhancing human capacities. West Sussex: Wiley-Blackwell.
   Google Scholar
• Selznick, P. (1996). Institutionalism “old” and “new”. Administrative Science Quarterly, 1, 270–277.
   Web of Science ®Google Scholar
• Slack, T. (2014). The social and commercial impact of sport, the role of sport management. European Sport Management Quarterly, 14(5), 454–463.
   Web of Science ®Google Scholar
• Smith, E. (2014). Should we fear the role-modelling impact of the anti-doping legislation? International Journal of Sport Policy and Politics, 6(2), 273–280.
   Google Scholar
• Smith, A. C., & Westerbeek, H. M. (2007). Sport as a vehicle for deploying corporate social responsibility. The Journal of Corporate Citizenship, 25, 43–54.
   Google Scholar
• Solberg, H. A., Hanstad, D. V., & Thøring, T. A. (2010). Doping in elite sport-do the fans care? Public opinion on the consequences of doping scandals. International Journal of Sports Marketing & Sponsorship, 11(3), 185–199.
   Web of Science ®Google Scholar
• Spruit, A., Van Vugt, E., van der Put, C., van der Stouwe, T., & Stams, G. J. (2016). Sports participation and juvenile delinquency: A meta-analytic review. Journal of Youth and Adolescence, 45(4), 655–671.
   PubMed Web of Science ®Google Scholar
• Stewart, B., & Smith, A. (2014). Rethinking drug use in sport. Oxon: Routledge.
   Google Scholar
• Summers, J., & Johnson, M. (1999). Segmentation of the Australian sport market. In A. Manrai & L. Meadow ( Eds.), Global perspectives in marketing for the 21st century (pp. 481–486). Heidelberg: Springer International.
   Google Scholar
• Swann, J. (2015). The history of efforts to regulate dietary supplements in the USA. Drug Testing and Analysis, 8(3–4), 271–282. doi:10.1002/dta.1919
   Web of Science ®Google Scholar
• Tscholl, P., Alonso, J., Dollé, G., Junge, A., & Dvorak, J. (2010). The use of drugs and nutritional supplements in top-level track and field athletes. American Journal of Sports Medicine, 38(1), 133–140.
   PubMed Web of Science ®Google Scholar
• Tscholl, P., Feddermann, N., Junge, A., & Dvorak, J. (2009). The use and abuse of Painkillers in international soccer data from 6 FIFA tournaments for female and youth players. The American Journal of Sports Medicine, 37(2), 260–265.
   PubMed Web of Science ®Google Scholar
• Tscholl, P., Junge, A., & Dvorak, J. (2008). The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006. British Journal of Sports Medicine, 42(9), 725–730.
   PubMed Web of Science ®Google Scholar
• Tsitsimpikou, C., Tsiokanos, A., Tsarouhas, K., Schamasch, P., Fitch, K. D., Valasiadis, D., & Jamurtas, A. (2009). Medication use by athletes at the Athens 2004 Summer Olympic Games. Clinical Journal of Sport Medicine, 19(1), 33–38.
   PubMed Web of Science ®Google Scholar
• Van Reeth, D. (2013). TV demand for the Tour de France: The importance of stage characteristics versus outcome uncertainty, patriotism, and doping. International Journal of Sport Finance, 8, 39–60.
   Web of Science ®Google Scholar
• Waddingston, I., (2006). Ethics problems in the medical management of sports injuries. In S. Loland, B. Skirstad, & I. Waddington ( Eds.), Pain and injury in sport: Social and ethical analysis (pp. 182–199). Abingdon: Routledge.
   Google Scholar